[The effect of opsonins on erythrocytes' phagocytosis in the vitreous--clinical observations (Part B)].
OBJECTIVE
We demonstrate clinical material collected during several years, which illustrates the possibilities of immunotherapy in intravitreous hemorrhages.


METHODS
Immunotherapy was applied in 172 persons, Rh-positive in 174 eyes with intravitreal hemorrhages of a various etiology. The therapy consisted of injecting preparations containing IgG anti RhD antibodies into the vitreous.


RESULTS
Visual acuity improvement has been obtained in 77.6% of eyes.


CONCLUSIONS
Summing up the effects of immunotherapy of hemorrhages into the vitreous body, it is necessary to stress the simplicity of performance of the procedure, its insignificant invasions and security resulting from the application of natural, human immunoglobulin.
Raczyńska
Krystyna
K
Katedry i Kliniki Chorób Oczu Akademii Medycznej w Gdańsku.
Iwaszkiewicz-Bilikiewicz
Barbara
B
D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D009895:Opsonin Proteins / Q000276:immunology; D010587:Phagocytosis / Q000276:immunology; D018029:Rho(D) Immune Globulin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014792:Visual Acuity; D014822:Vitreous Body / Q000276:immunology; D014823:Vitreous Hemorrhage / Q000628:therapy*
D009895:Opsonin Proteins; D018029:Rho(D) Immune Globulin